Literature DB >> 29469975

Biological activities of 3,4,5-trihydroxypiperidines and their N- and O-derivatives.

Kate Prichard1,2, David Campkin1,2, Nicholas O'Brien1,2, Atsushi Kato3, George W J Fleet4, Michela I Simone1,2.   

Abstract

3,4,5-Trihydroxypiperidines belong to the family of 1,5-dideoxy-1,5-iminosugar natural products and are structural analogues of pentose monosaccharides in the pyranose form. The biological activities of these apparently structurally simple molecules and their N- and O-alkylated and -arylated derivatives are no less remarkable than their C-6 hydroxymethyl counterparts of the hexoses (such as 1-deoxynojirimycin, DNJ). Their biological profiles indicate that the hydroxymethyl branch is crucial to neither potency nor selectivity, with O-alkylation demonstrated to produce exquisite selectivity extending beyond glycosidase inhibition, to immunosuppressant and antibacterial activities.
© 2018 John Wiley & Sons A/S.

Entities:  

Keywords:  anti-bacterial; anti-diabetes; glycosidase; iminosugar; immunosuppressant; lysosomal disease; piperidine

Mesh:

Substances:

Year:  2018        PMID: 29469975     DOI: 10.1111/cbdd.13182

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  7 in total

1.  Stereoselective Synthesis of C-2 Alkylated Trihydroxypiperidines: Novel Pharmacological Chaperones for Gaucher Disease.

Authors:  Francesca Clemente; Camilla Matassini; Andrea Goti; Amelia Morrone; Paolo Paoli; Francesca Cardona
Journal:  ACS Med Chem Lett       Date:  2019-02-08       Impact factor: 4.345

2.  Borylated 2,3,4,5-Tetrachlorophthalimide and Their 2,3,4,5-Tetrachlorobenzamide Analogues: Synthesis, Their Glycosidase Inhibition and Anticancer Properties in View to Boron Neutron Capture Therapy.

Authors:  David M Campkin; Yuna Shimadate; Barbara Bartholomew; Paul V Bernhardt; Robert J Nash; Jennette A Sakoff; Atsushi Kato; Michela I Simone
Journal:  Molecules       Date:  2022-05-26       Impact factor: 4.927

3.  Synthesis of a New β-Galactosidase Inhibitor Displaying Pharmacological Chaperone Properties for GM1 Gangliosidosis.

Authors:  Francesca Clemente; Macarena Martínez-Bailén; Camilla Matassini; Amelia Morrone; Silvia Falliano; Anna Caciotti; Paolo Paoli; Andrea Goti; Francesca Cardona
Journal:  Molecules       Date:  2022-06-22       Impact factor: 4.927

4.  Synthesis of modified 1,5-imino-d-xylitols as ligands for lysosomal β-glucocerebrosidase.

Authors:  Manuel Zoidl; Andreas Wolfsgruber; Michael Schalli; Seyed A Nasseri; Patrick Weber; Arnold E Stütz; Stephen G Withers; Tanja M Wrodnigg
Journal:  Monatsh Chem       Date:  2019-05-11       Impact factor: 1.451

5.  Safety assessment of a standardized cucumber extract (Q-Actin): Oral repeat-dose toxicity and mutagenicity studies.

Authors:  S Kothari; M Saravana; S Muthusamy; A Mozingo; M Soni
Journal:  Toxicol Rep       Date:  2018-10-28

6.  Synthesis of "All-Cis" Trihydroxypiperidines from a Carbohydrate-Derived Ketone: Hints for the Design of New β-Gal and GCase Inhibitors.

Authors:  Maria Giulia Davighi; Francesca Clemente; Camilla Matassini; Amelia Morrone; Andrea Goti; Macarena Martínez-Bailén; Francesca Cardona
Journal:  Molecules       Date:  2020-10-02       Impact factor: 4.411

Review 7.  Multivalent Pyrrolidine Iminosugars: Synthesis and Biological Relevance.

Authors:  Yali Wang; Jian Xiao; Aiguo Meng; Chunyan Liu
Journal:  Molecules       Date:  2022-08-24       Impact factor: 4.927

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.